NKTR
Price
$23.74
Change
-$1.26 (-5.04%)
Updated
Jul 28, 04:59 PM (EDT)
Capitalization
409.16M
9 days until earnings call
SLS
Price
$1.78
Change
-$0.02 (-1.11%)
Updated
Jul 28, 04:59 PM (EDT)
Capitalization
177.6M
9 days until earnings call
Interact to see
Advertisement

NKTR vs SLS

Header iconNKTR vs SLS Comparison
Open Charts NKTR vs SLSBanner chart's image
Nektar Therapeutics
Price$23.74
Change-$1.26 (-5.04%)
Volume$5.62K
Capitalization409.16M
SELLAS Life Sciences Group
Price$1.78
Change-$0.02 (-1.11%)
Volume$4.4K
Capitalization177.6M
NKTR vs SLS Comparison Chart in %
Loading...
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NKTR vs. SLS commentary
Jul 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NKTR is a StrongBuy and SLS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 29, 2025
Stock price -- (NKTR: $23.65 vs. SLS: $1.78)
Brand notoriety: NKTR: Notable vs. SLS: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NKTR: 25% vs. SLS: 36%
Market capitalization -- NKTR: $409.16M vs. SLS: $177.6M
NKTR [@Biotechnology] is valued at $409.16M. SLS’s [@Biotechnology] market capitalization is $177.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NKTR’s FA Score shows that 0 FA rating(s) are green whileSLS’s FA Score has 0 green FA rating(s).

  • NKTR’s FA Score: 0 green, 5 red.
  • SLS’s FA Score: 0 green, 5 red.
According to our system of comparison, SLS is a better buy in the long-term than NKTR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NKTR’s TA Score shows that 5 TA indicator(s) are bullish while SLS’s TA Score has 4 bullish TA indicator(s).

  • NKTR’s TA Score: 5 bullish, 5 bearish.
  • SLS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, NKTR is a better buy in the short-term than SLS.

Price Growth

NKTR (@Biotechnology) experienced а -4.60% price change this week, while SLS (@Biotechnology) price change was -3.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.28%. For the same industry, the average monthly price growth was +17.90%, and the average quarterly price growth was +45.83%.

Reported Earning Dates

NKTR is expected to report earnings on Aug 07, 2025.

SLS is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+4.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NKTR($409M) has a higher market cap than SLS($178M). SLS (71.154) and NKTR (69.534) have similar YTD gains . SLS has higher annual earnings (EBITDA): -27.93M vs. NKTR (-97.97M). NKTR has more cash in the bank: 219M vs. SLS (28.4M). SLS has less debt than NKTR: SLS (870K) vs NKTR (100M). NKTR has higher revenues than SLS: NKTR (87.2M) vs SLS (0).
NKTRSLSNKTR / SLS
Capitalization409M178M230%
EBITDA-97.97M-27.93M351%
Gain YTD69.53471.15498%
P/E RatioN/AN/A-
Revenue87.2M0-
Total Cash219M28.4M771%
Total Debt100M870K11,494%
FUNDAMENTALS RATINGS
NKTR vs SLS: Fundamental Ratings
NKTR
SLS
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
55
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
3740
P/E GROWTH RATING
1..100
85100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SLS's Valuation (55) in the Biotechnology industry is in the same range as NKTR (83). This means that SLS’s stock grew similarly to NKTR’s over the last 12 months.

SLS's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as NKTR (100). This means that SLS’s stock grew similarly to NKTR’s over the last 12 months.

SLS's SMR Rating (99) in the Biotechnology industry is in the same range as NKTR (99). This means that SLS’s stock grew similarly to NKTR’s over the last 12 months.

NKTR's Price Growth Rating (37) in the Biotechnology industry is in the same range as SLS (40). This means that NKTR’s stock grew similarly to SLS’s over the last 12 months.

NKTR's P/E Growth Rating (85) in the Biotechnology industry is in the same range as SLS (100). This means that NKTR’s stock grew similarly to SLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NKTRSLS
RSI
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
82%
Momentum
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
81%
MACD
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 12 days ago
76%
Bullish Trend 26 days ago
86%
Declines
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLFN31.42N/A
N/A
Home Loan Financial Corp.
LVWD0.14N/A
N/A
LiveWorld, Inc.
MXCHF0.72N/A
N/A
Orbia Advance Corp S A B
CHTH2.90N/A
N/A
CNL Healthcare Pptys Inc.
NPSCY6.56-0.13
-1.94%
Nippon Steel Corporation